Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)

TPE:1720 Revenue

Standard Chemical & Pharmaceutical had revenue of 1.65B TWD in the quarter ending March 31, 2026, with 0.72% growth. This brings the company's revenue in the last twelve months to 7.03B, up 3.22% year-over-year. In the year 2025, Standard Chemical & Pharmaceutical had annual revenue of 7.02B with 3.44% growth.

• Revenue (ttm): 7.03B
• Revenue Growth: +3.22%
• P/S Ratio: 1.56
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 11.01B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.02B	233.80M	3.44%
Dec 31, 2024	6.79B	549.46M	8.81%
Dec 31, 2023	6.24B	388.40M	6.64%
Dec 31, 2022	5.85B	1.25B	27.09%
Dec 31, 2021	4.60B	298.68M	6.94%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error